- Following UPSIDE’s historic FDA “green light” in 2022, UPSIDE Foods today announced another historic milestone – label approval for its cell-cultivated chicken
- With this label approval, UPSIDE has one remaining step in the regulatory review process before it can start commercial production and sales – a USDA Grant of Inspection (GOI) for its Engineering, Production, and Innovation Center (EPIC)
BERKELEY, Calif., June 14, 2023 /PRNewswire/ — UPSIDE Foods, the leading cultivated meat, poultry and seafood company, announced today that it obtained label approval for its cultivated chicken from the U.S. Department of Agriculture (USDA). With an approved label in hand, UPSIDE Foods is now working with USDA to obtain a Grant of Inspection (GOI) for its Engineering, Production, and Innovation Center (EPIC), the last remaining item in the pre-market regulatory process before the company can commercially produce and sell its cultivated chicken in the United States. The label uses the term “cell-cultivated chicken.”
As a cultivated meat product grown directly from real animal cells, UPSIDE’s Chicken is subject to the same labeling requirements as conventionally-produced meat products. UPSIDE Foods has now demonstrated full compliance with all pre-market requirements for labeling and can begin commercial production and sales as soon as it obtains a GOI from USDA. UPSIDE’s chicken will proudly bear the USDA mark of inspection on its packaging after it passes USDA inspection.
“The USDA’s approval of our label marks a major step forward towards our goal of creating a more humane and sustainable food system,” said Dr. Uma Valeti, CEO and Founder of UPSIDE Foods. “We’re excited to continue working with the USDA to achieve our next milestone: a Grant of Inspection (GOI) for our facility. Obtaining the USDA’s GOI will clear the way for commercial production and sales and allow us to bring our delicious UPSIDE chicken to consumers for the first time.”
** Click here to read the full-text **
